Anne A. Finucane - 20 Nov 2025 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
Director
Signature
/s/ Anne M. Finucane
Issuer symbol
CVS
Transactions as of
20 Nov 2025
Net transactions value
+$179,940
Form type
4
Filing time
21 Nov 2025, 17:41:35 UTC
Previous filing
05 Nov 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Finucane Anne A. Director ONE CVS DRIVE, WOONSOCKET /s/ Anne M. Finucane 21 Nov 2025 0001511491

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Award $44,940 +591 $76.04 591 20 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Deferred Stock Units Award $135,000 +1,775 +12% $76.04 16,530 20 Nov 2025 Common Stock 1,775 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F2 Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F3 Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.